ORION PHARMA A/S: Financial statements 2019
CVR: 20601116
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
ORION PHARMA A/S (CVR 20601116) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK 280,861,600 and a net result of DKK 16,907,454 compared with DKK 20,524,490 the year before. That is an increase of 13.7% compared with the year before. The profit margin was 6%. Equity in the 2019 report amounted to DKK 57,594,879. The solvency ratio was 60.3%. The company had 24 employees in the financial year.
- Revenue
- DKK 280,861,600
- Gross Profit
- DKK 42,968,514
- Profit/Loss
- DKK 16,907,454
- Equity
- DKK 57,594,879
- Total Assets
- DKK 95,486,243
- Employees
- 24
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | 280.9 mio. | 43 mio. | 16.9 mio. | 57.6 mio. | 24 |
| 2018 | 247.1 mio. | 51 mio. | 20.5 mio. | 50.7 mio. | 28 |
| 2017 | 327.7 mio. | 73 mio. | 37.8 mio. | 95.2 mio. | 29 |
| 2016 | 373.7 mio. | 101 mio. | 56.7 mio. | 97.3 mio. | 29 |
| 2015 | 273 mio. | 85.3 mio. | 44.8 mio. | 66.6 mio. | 28 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
ORION PHARMA A/S has published its annual report for 2018. Revenue came to DKK 247,118,144, and the net result was DKK 20,524,490.
About ORION PHARMA A/S
ORION PHARMA A/S is a Danish company of the type Aktieselskab based in København S, founded in 1953. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ERCOPHARM A/S. The management consists of Jesper Otto Qvist-Pedersen. The board consists of Satu Maarit Ahomäki (chair), Mikko Tapani Kemppainen and René Kristian Lindell. The company is owned by Orion Corporation. The company has 14 employees (2026). In 2025, the company reported revenue of DKK 329,561,856 and a net result of DKK 10,525,947 compared with DKK 10,899,639 the year before. Equity in the 2025 report amounted to DKK 32,510,625.